Kindler H - Search Results

1

Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.

Medved M, Karczmar G, Yang C, Dignam J, Gajewski TF, Kindler H, Vokes E, MacEneany P, Mitchell MT, Stadler WM. Medved M, et al. Among authors: kindler h. J Magn Reson Imaging. 2004 Jul;20(1):122-8. doi: 10.1002/jmri.20061. J Magn Reson Imaging. 2004. PMID: 15221817 Clinical Trial.

2

Phase II study of flavopiridol in patients with advanced colorectal cancer.

Aklilu M, Kindler HL, Donehower RC, Mani S, Vokes EE. Aklilu M, et al. Among authors: kindler hl. Ann Oncol. 2003 Aug;14(8):1270-3. doi: 10.1093/annonc/mdg343. Ann Oncol. 2003. PMID: 12881391 Free article. Clinical Trial.

3

9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium.

Kindler HL, Avadhani A, Wade-Oliver K, Karrison T, Mani S, Vokes EE. Kindler HL, et al. Invest New Drugs. 2004 Aug;22(3):323-7. doi: 10.1023/B:DRUG.0000026259.28395.c2. Invest New Drugs. 2004. PMID: 15122080 Clinical Trial.

4

A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer.

Eng C, Kindler HL, Nattam S, Ansari RH, Kasza K, Wade-Oliver K, Vokes EE. Eng C, et al. Among authors: kindler hl. Ann Oncol. 2004 Jun;15(6):928-32. doi: 10.1093/annonc/mdh236. Ann Oncol. 2004. PMID: 15151950 Free article. Clinical Trial.

5

Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.

Ryan CW, Vogelzang NJ, Vokes EE, Kindler HL, Undevia SD, Humerickhouse R, André AK, Wang Q, Carr RA, Ratain MJ. Ryan CW, et al. Clin Cancer Res. 2004 Jul 1;10(13):4406-11. doi: 10.1158/1078-0432.CCR-04-0083. Clin Cancer Res. 2004. PMID: 15240529 Clinical Trial.

6

Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.

Desai AA, Kindler HL, Taber D, Agamah E, Mani S, Wade-Oliver K, Ratain MJ, Vokes EE. Desai AA, et al. Cancer Chemother Pharmacol. 2005 Oct;56(4):421-6. doi: 10.1007/s00280-005-1020-5. Epub 2005 May 13. Cancer Chemother Pharmacol. 2005. PMID: 15895230 Clinical Trial.

7

Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer.

Kindler HL, Friberg G, Skoog L, Wade-Oliver K, Vokes EE. Kindler HL, et al. Am J Clin Oncol. 2005 Aug;28(4):340-4. doi: 10.1097/01.coc.0000159558.19631.d5. Am J Clin Oncol. 2005. PMID: 16062074 Clinical Trial.

8

Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers.

Kindler HL, Tothy PK, Wolff R, McCormack RA, Abbruzzese JL, Mani S, Wade-Oliver KT, Vokes EE. Kindler HL, et al. Invest New Drugs. 2005 Oct;23(5):489-93. doi: 10.1007/s10637-005-2909-x. Invest New Drugs. 2005. PMID: 16133801 Clinical Trial.

9

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.

Kindler HL, Friberg G, Singh DA, Locker G, Nattam S, Kozloff M, Taber DA, Karrison T, Dachman A, Stadler WM, Vokes EE. Kindler HL, et al. J Clin Oncol. 2005 Nov 1;23(31):8033-40. doi: 10.1200/JCO.2005.01.9661. J Clin Oncol. 2005. PMID: 16258101 Clinical Trial.

10

The cancer and leukemia group B respiratory committee.

Vokes EE, Perry MC, Kindler HL, Green MR. Vokes EE, et al. Clin Cancer Res. 2006 Jun 1;12(11 Pt 2):3581s-8s. doi: 10.1158/1078-0432.CCR-06-9015. Clin Cancer Res. 2006. PMID: 16740789 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters